Health Trials

KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

ConditionPTSD and Trauma-related Symptoms
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-65
SponsorIrma Fleming

About this trial

A study looking at the safety and tolerability of KAP (Ketamine-Assisted Psychotherapy) in the burn population.

Eligibility criteria

Qualifiers

Subjects 18 - 65 yrs with > 15 % Total Body Surface Area Burns.

National Stressful Events Survey Acute Stress Disorder Short Scale (NSESSS) average total score>= 2 (severity scale of none (0), mild (1), moderate (2), severe (3), or extreme (4) ) prior to discharge from UUH.

Disqualifiers

Allergy or previous adverse reactions to ketamine

Pending surgical interventions

Active systemic infection, sepsis, or hemodynamic instability

Physical limitations from burn injury that preclude safe travel to outpatient visits or positioning for therapy.

Trial design

Treatments tested in this trial

  • Preparatory Session
  • Ketamine-assisted Psychotherapy Session #1
  • Ketamine-assisted Psychotherapy Session #2
  • Integration Session

Treatment groups

12 Participants
are divided into 1 treatment group

Sponsors and collaborators

Irma Fleming

Lead sponsor

University of Utah

Sponsor institution

University of Utah

Collaborator

Source ClinicalTrials.gov